TMED vs. USFI

Last updated Aug 4, 2026

TMED (T. Rowe Price Health Care ETF) and USFI (BrandywineGLOBAL - U.S. Fixed Income ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund actively managed by T. Rowe Price, while USFI is a Actively Managed fund actively managed by BrandywineGLOBAL. Both are actively managed. Over the past year, TMED returned 41.69% vs 3.00% for USFI. Their 0.23 correlation means their historical movements had little consistent relationship. TMED charges 0.44%/yr vs 0.39%/yr for USFI.

Performance

TMED vs. USFI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and BrandywineGLOBAL - U.S. Fixed Income ETF (USFI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TMED achieves a 14.31% return, which is significantly higher than USFI's 0.70% return.

TMED

• 1D: 0.28%
• 1M: -2.90%
• 6M: 13.93%
• YTD: 14.31%
• 1Y: 41.69%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 31.40%

USFI

• 1D: 0.14%
• 1M: -0.69%
• 6M: 0.68%
• YTD: 0.70%
• 1Y: 3.00%
• 3Y*: 4.06%
• 5Y*: —
• 10Y*: —
• ALL TIME*: 3.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
TMED T. Rowe Price Health Care ETF	$590.48K	$387.83K	$177.93K
USFI BrandywineGLOBAL - U.S. Fixed Income ETF	$223.65	$248.36	$6.79K

TMED vs. USFI - Yearly Performance Comparison

	2026 (YTD)	2025
TMED T. Rowe Price Health Care ETF	14.31%	19.49%
USFI BrandywineGLOBAL - U.S. Fixed Income ETF	0.70%	4.73%

Correlation

The correlation between TMED and USFI is 0.25, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.25
Correlation (All Time) Calculated using the full available price history since Jun 12, 2025	0.23

Return for Risk

TMED vs. USFI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TMED

TMED Risk / Return Rank: 87
TMED Sharpe Ratio Rank: 88
TMED Sortino Ratio Rank: 89
TMED Omega Ratio Rank: 85
TMED Calmar Ratio Rank: 87
TMED Martin Ratio Rank: 84

USFI

USFI Risk / Return Rank: 46
USFI Sharpe Ratio Rank: 36
USFI Sortino Ratio Rank: 37
USFI Omega Ratio Rank: 34
USFI Calmar Ratio Rank: 71
USFI Martin Ratio Rank: 50

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TMED vs. USFI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and BrandywineGLOBAL - U.S. Fixed Income ETF (USFI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TMED	USFI	Difference
Sharpe ratio: Return per unit of total volatility	2.29	0.98	+1.31
Sortino ratio: Return per unit of downside risk	3.32	1.52	+1.80
Omega ratio: Gain probability vs. loss probability	1.39	1.18	+0.22
Calmar ratio: Return relative to maximum drawdown	3.77	2.72	+1.05
Martin ratio: Return relative to average drawdown	12.83	6.29	+6.54

TMED vs. USFI - Sharpe Ratio Comparison

The current TMED Sharpe Ratio is 2.29, which is higher than the USFI Sharpe Ratio of 0.98. The chart below compares the historical Sharpe Ratios of TMED and USFI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TMED vs. USFI - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, which is greater than USFI's maximum drawdown of -8.47%. Use the drawdown chart below to compare losses from any high point for TMED and USFI.

Drawdown Indicators

	TMED	USFI	Difference
Max Drawdown Largest peak-to-trough decline	-11.11%	-8.47%	-2.64%
Max Drawdown (1Y) Largest decline over 1 year	-11.11%	-1.11%	-10.00%
Max Drawdown (3Y) Largest decline over 3 years	—	-7.69%	—
Current Drawdown Current decline from peak	-3.98%	-0.86%	-3.12%
Average Drawdown Average peak-to-trough decline	-2.42%	-2.06%	-0.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.26%	0.48%	+2.78%

Volatility

TMED vs. USFI - Volatility Comparison

T. Rowe Price Health Care ETF (TMED) has a higher volatility of 4.81% compared to BrandywineGLOBAL - U.S. Fixed Income ETF (USFI) at 0.73%. This indicates that TMED's price experiences larger fluctuations and is considered to be riskier than USFI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TMED	USFI	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.81%	0.73%	+4.08%
Volatility (6M) Calculated over the trailing 6-month period	14.06%	1.66%	+12.40%
Volatility (1Y) Calculated over the trailing 1-year period	18.29%	3.08%	+15.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.11%	6.84%	+11.27%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.11%	6.84%	+11.27%

TMED vs. USFI - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is higher than USFI's 0.39% expense ratio.

Dividends

TMED vs. USFI - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.48%, less than USFI's 4.51% yield.

Position	TTM	2025	2024	2023
TMED T. Rowe Price Health Care ETF	0.48%	0.54%	0.00%	0.00%
USFI BrandywineGLOBAL - U.S. Fixed Income ETF	4.51%	4.42%	4.60%	1.83%

Frequently Asked Questions

Can I hold both TMED and USFI in my portfolio?

TMED and USFI have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TMED or USFI?

TMED has higher volatility (4.81%) compared to USFI (0.73%). In terms of maximum drawdown, TMED dropped -11.11% vs USFI's -8.47%.

Which ETF is better, TMED or USFI?

On 1-year performance, TMED leads with 41.69% vs 3.00% for USFI. On fees, USFI is cheaper at 0.39% per year. On volatility, USFI has been the lower-risk option at 0.73%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, TMED or USFI?

Over the 1-year period, TMED has performed better with a 41.69% return vs 3.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, TMED or USFI?

USFI is cheaper with a 0.39% expense ratio, compared with 0.44% for TMED.

Which ETF pays a higher dividend yield, TMED or USFI?

USFI has the higher dividend yield at 4.51%, compared with 0.48% for TMED.

What is the main difference between TMED and USFI?

TMED is categorized as Health & Biotech Equities, while USFI is Actively Managed. They also come from different issuers: T. Rowe Price and BrandywineGLOBAL. Their fees differ too: 0.44% for TMED and 0.39% for USFI.

Which has better risk-adjusted returns?

TMED currently has the higher Sharpe Ratio (2.29 vs 0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.